Avoid common mistakes on your manuscript.
Guest Editor
Livio Garattini
CESAV, Center for Health Economics, IRCCS Institute for Pharmacological Research ‘Mario Negri’, Via Camozzi 3, 24020 Ranica, Italy
Peer Reviewer
Albert I. Wertheimer, PhD, MBA
Professor of Pharmacy Economics, Temple University School of Pharmacy, Philadelphia, PA 19140, USA
The supplement has been financially supported by Abbott Products Operations AG, Established Pharmaceuticals Division.
Conflicts of Interest
The research reported in this supplement has been funded by the sponsor of the supplement. All research has been reviewed and guided by an International Outcomes Research Board (IORB) chaired by Prof. Dr. Nikos Maniadakis (Greece) and with the following members: Prof. Dr. Diana I Brixner (USA), Prof. Dr. Marcos Bosi Ferraz (Brazil), Prof. Dr. Shanlian Hu (China), Prof. Dr. Zoltan Kalo (Hungary), Prof. Dr. Else-Lydia Toverud (Norway), Dr. Rafael Alfonso (USA and Columbia), Prof. Dr. Suracht Ngoraches (Thailand). The supplement was guest edited by Livio Garattini and peer reviewed by Albert Wertheimer, neither of whom received any funding for doing so.
Rights and permissions
About this article
Cite this article
Off-Patent Medicines Policies in the Quest for Value in Global Healthcare. Appl Health Econ Health Policy 13 (Suppl 1), 1 (2015). https://doi.org/10.1007/s40258-015-0187-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40258-015-0187-0